Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (4072)	12/17/2001 11:20:27 PM
From: Mark Marcellus	Read Replies (1) \| Respond to of 5582

If you think everyone is going to prefer a doctor's prescription and a pill for a cold...well, whose kidding whom. Try not to be so boorish, Mark. Re the pill popping, I wasn't suggesting that everyone prefers pills. If it makes you feel better, we can even call the people who prefer nasal sprays "the elite few". Total sales in millions (Mass channels, food, and drugs combined) for year ending Dec 31, 2000: Cold/Allergy Sinus Tablet: $1564.9 Cold/Allergy Sinus Liquid: $623.9 Cough/Sore Throat Drops: $411.7 Cough Syrup: $356.3 Nasal Spray: $$382.4 Source: Information Resources Inc. I don't have any statistics handy for the number of people who prefer unproven OTC remedies over doctor prescribed remedies which have been proven effective, but I agree that the number for the former will be greater than zero. You might even be able to find some correlation between that group and the group of people who invest in penny stocks. That would certainly cut down on the marketing costs when GUMM tries to identify potential customers for their two largest selling products.